1	Un	Un		C0205447_1	calificador_1	0-2	31_QUEST_clinical_caseMIR	SENT1	-	-
2	paciente	paciente	NCCS000	C0030705	persona	3-11	31_QUEST_clinical_caseMIR	SENT1	-	-
3	de	de	SPS00	C0332285	atributo	12-14	31_QUEST_clinical_caseMIR	SENT1	-	-
4	74	74		-	-	15-17	31_QUEST_clinical_caseMIR	SENT1	-	-
5	años	año	NCMP000	C0439234	calificador	18-22	31_QUEST_clinical_caseMIR	SENT1	-	-
6	de	de	SPS00	C0001779_1	entidad_observable_1	23-25	31_QUEST_clinical_caseMIR	SENT1	-	-
7	edad	edad	NCFS000	C0001779_2	entidad_observable_2	26-30	31_QUEST_clinical_caseMIR	SENT1	-	-
8	es	ser	VSIP3S0	-	-	31-33	31_QUEST_clinical_caseMIR	SENT1	-	-
9	diagnosticado	diagnosticar	VMP00SM	-	-	34-47	31_QUEST_clinical_caseMIR	SENT1	-	-
10	de	de	SPS00	C0332285	atributo	48-50	31_QUEST_clinical_caseMIR	SENT1	-	-
11	leucemia	leucemia	NCFS000	C0023418	anomalía_morfológica#trastorno	51-59	31_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
12	linfática	linfático	NCFS000	C0229889	estructura_corporal	60-69	31_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
13	crónica	crónico	AQ0FS0	C0205191	calificador	70-77	31_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
14	B	b	NCFS000	-	-	78-79	31_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
15	estadio	estadio	NCMS000	C1306673#C0442588	atributo#medio_ambiente	80-87	31_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
16	HB	hb	NC00YL0	-	-	88-90	31_QUEST_clinical_caseMIR	SENT1	I-Calificador	-
17	de	de	SPS00	C0332285	atributo	91-93	31_QUEST_clinical_caseMIR	SENT1	-	-
18	RAI-BINNET	rai-binnet	NCCN000	-	-	94-104	31_QUEST_clinical_caseMIR	SENT1	-	-
19	.	.	Fp	-	-	104-105	31_QUEST_clinical_caseMIR	SENT1	-	-

1	Tras	tras	SPS00	-	-	106-110	31_QUEST_clinical_caseMIR	SENT2	-	-
2	recibir	recibir	VMN0000	-	-	111-118	31_QUEST_clinical_caseMIR	SENT2	-	-
3	6	6		-	-	119-120	31_QUEST_clinical_caseMIR	SENT2	-	-
4	ciclos	ciclo	NCMP000	-	-	121-127	31_QUEST_clinical_caseMIR	SENT2	-	-
5	de	de	SPS00	C0332285	atributo	128-130	31_QUEST_clinical_caseMIR	SENT2	-	-
6	fluradabina	fluradabina	NCFS000	-	-	131-142	31_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
7	,	,	Fc	-	-	142-143	31_QUEST_clinical_caseMIR	SENT2	-	-
8	presenta	presentar	VMIP3S0	-	-	144-152	31_QUEST_clinical_caseMIR	SENT2	-	-
9	astenia	astenia	NCFS000	C0004093#C3714552	hallazgo	153-160	31_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
10	importante	importante	AQ0CS0	-	-	161-171	31_QUEST_clinical_caseMIR	SENT2	B-Calificador	-
11	y	y	CC	C1706368	calificador	172-173	31_QUEST_clinical_caseMIR	SENT2	-	-
12	palidez	palidez	NCFS000	C0030232#C1275397	hallazgo	174-181	31_QUEST_clinical_caseMIR	SENT2	B-Grp_Enfermedad	-
13	de	de	SPS00	C0332285	atributo	182-184	31_QUEST_clinical_caseMIR	SENT2	-	-
14	la	el	DA0FS0	-	-	185-187	31_QUEST_clinical_caseMIR	SENT2	-	-
15	piel	piel	NCFS000	C1278993#C0037262#C1123023	estructura_corporal	188-192	31_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
16	y	y	CC	C1706368	calificador	193-194	31_QUEST_clinical_caseMIR	SENT2	-	-
17	mucosas	mucosa	NCFP000	C0026724	estructura_corporal	195-202	31_QUEST_clinical_caseMIR	SENT2	B-Estructura_Corporal	-
18	.	.	Fp	-	-	202-203	31_QUEST_clinical_caseMIR	SENT2	-	-

1	En	en	SPS00	C1720294#C0332285	calificador#atributo	204-206	31_QUEST_clinical_caseMIR	SENT3	-	-
2	la	el	DA0FS0	-	-	207-209	31_QUEST_clinical_caseMIR	SENT3	-	-
3	analítica	analítica	NCFS000	-	-	210-219	31_QUEST_clinical_caseMIR	SENT3	-	-
4	destaca	destacar	VMIP3S0	-	-	220-227	31_QUEST_clinical_caseMIR	SENT3	-	-
5	.	.	Fp	-	-	227-228	31_QUEST_clinical_caseMIR	SENT3	-	-
6	leucocitos	leucocito	NCMP000	C0023516	célula	229-239	31_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
7	5600/uL	5600/uL		-	-	240-247	31_QUEST_clinical_caseMIR	SENT3	-	-
8	con	con	SPS00	C0332287	atributo	248-251	31_QUEST_clinical_caseMIR	SENT3	-	-
9	fórmula	fórmula	NCFS000	-	-	252-259	31_QUEST_clinical_caseMIR	SENT3	-	-
10	normal	normal	AQ0CS0	C0205307	calificador	260-266	31_QUEST_clinical_caseMIR	SENT3	-	-
11	,	,	Fc	-	-	266-267	31_QUEST_clinical_caseMIR	SENT3	-	-
12	hemoglobina	hemoglobina	NCFS000	C0019046	sustancia	268-279	31_QUEST_clinical_caseMIR	SENT3	-	-
13	3	3	Z	-	-	280-281	31_QUEST_clinical_caseMIR	SENT3	-	-
14	gr	g	NC00SC0	-	-	282-284	31_QUEST_clinical_caseMIR	SENT3	-	-
15	/	/	Fh	-	-	284-285	31_QUEST_clinical_caseMIR	SENT3	-	-
16	dl	decilitro	NCMN000	C0439241	calificador	285-287	31_QUEST_clinical_caseMIR	SENT3	-	-
17	y	y	CC	C1706368	calificador	288-289	31_QUEST_clinical_caseMIR	SENT3	-	-
18	plaquetas	plaqueta	NCFP000	C0005821	estructura_corporal	290-299	31_QUEST_clinical_caseMIR	SENT3	B-Estructura_Corporal	-
19	250000/uL	250000/uL		-	-	300-309	31_QUEST_clinical_caseMIR	SENT3	-	-
20	.	.	Fp	-	-	309-310	31_QUEST_clinical_caseMIR	SENT3	-	-

1	Reticulocitos	reticulocito	NCMP000	C0035286	célula	311-324	31_QUEST_clinical_caseMIR	SENT4	B-Estructura_Corporal	-
2	0	0	Z	-	-	325-326	31_QUEST_clinical_caseMIR	SENT4	-	-
3	%	%	Ft	-	-	326-327	31_QUEST_clinical_caseMIR	SENT4	-	-
4	.	.	Fp	-	-	327-328	31_QUEST_clinical_caseMIR	SENT4	-	-

1	Niveles	nivel	NCMP000	C0456079	atributo	329-336	31_QUEST_clinical_caseMIR	SENT5	-	-
2	normales	normal	AQ0CP0	C0205307	calificador	337-345	31_QUEST_clinical_caseMIR	SENT5	-	-
3	de	de	SPS00	C0332285	atributo	346-348	31_QUEST_clinical_caseMIR	SENT5	-	-
4	LDH	ldh	NC00SC0	C0022917	sustancia	349-352	31_QUEST_clinical_caseMIR	SENT5	-	-
5	y	y	CC	C1706368	calificador	353-354	31_QUEST_clinical_caseMIR	SENT5	-	-
6	test	test	NCMS000	-	-	355-359	31_QUEST_clinical_caseMIR	SENT5	-	-
7	de	de	SPS00	C0332285	atributo	360-362	31_QUEST_clinical_caseMIR	SENT5	-	-
8	Coombs	coombs	NCMP000	-	-	363-369	31_QUEST_clinical_caseMIR	SENT5	-	-
9	directo	directo	AQ0MS0	C0439851	calificador	370-377	31_QUEST_clinical_caseMIR	SENT5	-	-
10	negativo	negativo	AQ0MS0	C0205160#C0549184	calificador	378-386	31_QUEST_clinical_caseMIR	SENT5	-	-
11	.	.	Fp	-	-	386-387	31_QUEST_clinical_caseMIR	SENT5	-	-

1	El	el	DA0MS0	-	-	388-390	31_QUEST_clinical_caseMIR	SENT6	-	-
2	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	391-402	31_QUEST_clinical_caseMIR	SENT6	-	-
3	más	más	RG	C0205172	calificador	403-406	31_QUEST_clinical_caseMIR	SENT6	-	-
4	probable	probable	AQ0CS0	C0332148	calificador	407-415	31_QUEST_clinical_caseMIR	SENT6	-	-
5	es	ser	VSIP3S0	-	-	416-418	31_QUEST_clinical_caseMIR	SENT6	-	-
6	.	.	Fp	-	-	418-419	31_QUEST_clinical_caseMIR	SENT6	-	-

